Peer mentoring program for managing psychological distress in IBD patients
A Randomized, Wait List-Controlled, Clinical Trial of IBD Strong Peer for Self-Management of Psychological Distress by Persons Living With Inflammatory Bowel Diseases (IBD)
This study tests whether a peer mentoring program can help adults with inflammatory bowel diseases feel better mentally during tough times like being newly diagnosed or facing surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Nova Scotia Health Authority Academic / other |
| Locations | 1 site (Halifax, N.S.) |
| Trial ID | NCT05722236 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on addressing psychological distress associated with inflammatory bowel diseases (IBD) through a peer-led mentoring program. The program is designed for adults experiencing transitions in their IBD journey, such as newly diagnosed patients or those facing surgery. Participants will receive virtual support from peers who understand their challenges, aiming to improve mental health outcomes. The study compares the peer mentoring intervention to a waitlist control group to evaluate its effectiveness.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are experiencing transitions in their IBD management.
Not a fit: Patients with severe psychological conditions or those who do not speak English may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve the mental health and overall well-being of patients living with IBD.
How similar studies have performed: Previous studies have shown that peer-led interventions can be effective in managing psychological distress in chronic illness populations, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult IBD patient (18 years or older) * In a period of transition (newly diagnosed, transitioning from pediatric to adult care, flaring or changing medications, recently admitted to hospital, or facing the need for surgery) Exclusion Criteria: * Screening positive for severe psychological pathology * Do not speak English * Diagnosis of a major comorbid psychiatric condition such as bipolar disorder or schizophrenia, * No access to the internet
Where this trial is running
Halifax, N.S.
- QEII Health Sciences Centre — Halifax, N.s., Canada (Recruiting)
Study contacts
- Study coordinator: Jennifer Jones, MD
- Email: jljones@dal.ca
- Phone: 902-473-1499
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.